Short answer · Medically reviewed summary · Last updated: 2026-04-07
The ICD-10 code for Ankylosing Spondylitis is M45, while the older ICD-9 classification is 720.0. These codes are essential for medical documentation, insurance billing, and tracking the prevalence of Ankylosing Spondylitis within healthcare systems worldwide. What is the clinical significance of the Ankylosing Spondylitis classification? Ankylosing Spondylitis is a chronic, systemic inflammatory rheumatic disease that primarily affects the axial skeleton, specifically the sacroiliac joints and the spine.
9 people with Ankylosing Spondylitis have shared their first-person experience on this question at DiseaseMaps.
The ICD-10 code for Ankylosing Spondylitis is M45, while the older ICD-9 classification is 720.0. These codes are essential for medical documentation, insurance billing, and tracking the prevalence of Ankylosing Spondylitis within healthcare systems worldwide.
Ankylosing Spondylitis is a chronic, systemic inflammatory rheumatic disease that primarily affects the axial skeleton, specifically the sacroiliac joints and the spine. By utilizing the specific ICD-10 code M45, rheumatologists can accurately document the progression of the disease, which often begins with inflammatory back pain and stiffness. Because Ankylosing Spondylitis can also manifest as peripheral joint involvement, such as shoulder or hip pain, precise coding ensures that multisystem complications—including those involving the digestive, muscular, and immune systems—are properly linked to the primary diagnosis.
Receiving a diagnosis of Ankylosing Spondylitis can be an overwhelming experience, often following years of unexplained back pain. Our community at DiseaseMaps.org, which currently includes 2,109 members living with Ankylosing Spondylitis, highlights that early and accurate coding is the first step toward accessing appropriate rheumatological care. While the condition can lead to significant skeletal changes, modern management strategies aim to reduce inflammation and maintain mobility, helping patients manage the physical and emotional burden of the disease.
Ankylosing Spondylitis is not merely a spinal condition; it is a systemic disease that requires a multidisciplinary approach. The following systems are frequently monitored by clinicians managing the condition:
Currently, there is no known cure for Ankylosing Spondylitis, but treatments have evolved significantly. While some patients explore herbal supplements to manage symptoms, these should never replace evidence-based medical treatments prescribed by a rheumatologist. Standard care for Ankylosing Spondylitis typically involves non-steroidal anti-inflammatory drugs (NSAIDs), physical therapy, and, in more severe cases, biologic disease-modifying antirheumatic drugs (DMARDs) to suppress the immune system's inflammatory response.
Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.